Here, we present data from two independent patient cohorts demonstrating that expression of the RNA-binding protein RBM3, both at the mRNA and protein levels, is associated with a good prognosis in epithelial ovarian cancer. This evidence concerns the gene RBM3 and ovarian carcinoma.